STABLE PHARMACEUTICAL COMPOSITIONS COMPRISING LIRAGLUTIDE AND DEGLUDEC
摘要
<p>Pharmaceutical composition for parenteral administration comprising a basal insulin peptide and an insulinotropic GLP-1 peptide comprising at least 6 zinc atoms per 6 insulin molecules.</p>
申请公布号
EP2209800(A2)
申请公布日期
2010.07.28
申请号
EP20080849536
申请日期
2008.11.14
申请人
NOVO NORDISK A/S
发明人
PLUM, ANNE;STEENSGAARD, DORTE, BJERRE;THOMSEN, JENS, KAALBY;SCHLEIN, MORTEN;MARKUSSEN, ANNE SOFIE, KJAER;POULSEN, CHRISTIAN
